Nord/LB Reiterates €31.00 Price Target for Evonik Industries (EVK)
Evonik Industries (FRA:EVK) received a €31.00 ($36.90) target price from analysts at Nord/LB in a report issued on Friday. The firm currently has a “neutral” rating on the stock. Nord/LB’s price objective suggests a potential downside of 2.45% from the company’s current price.
Other research analysts also recently issued research reports about the stock. UBS set a €27.00 ($32.14) price objective on shares of Evonik Industries and gave the company a “sell” rating in a report on Thursday. Berenberg Bank set a €33.00 ($39.29) price objective on shares of Evonik Industries and gave the company a “buy” rating in a report on Wednesday, August 16th. J P Morgan Chase & Co set a €25.00 ($29.76) price objective on shares of Evonik Industries and gave the company a “sell” rating in a report on Thursday, August 10th. DZ Bank reissued a “neutral” rating on shares of Evonik Industries in a report on Friday, November 3rd. Finally, Goldman Sachs Group set a €29.00 ($34.52) price objective on shares of Evonik Industries and gave the company a “neutral” rating in a report on Monday, November 6th. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and eleven have given a buy rating to the company. Evonik Industries presently has a consensus rating of “Hold” and an average price target of €33.75 ($40.18).
Evonik Industries (FRA:EVK) opened at €31.78 ($37.83) on Friday. Evonik Industries has a 1-year low of €26.78 ($31.88) and a 1-year high of €32.97 ($39.25).
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, animal nutrition, and healthcare sectors.
Receive News & Ratings for Evonik Industries AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries AG and related companies with MarketBeat.com's FREE daily email newsletter.